Last night I had the incredible pleasure of having dinner with Dr. Bobby Sandage, CEO, and Dr. Lucy Lu, CFO, of Coronado Biosciences (http://www.coronadobiosciences.com/
), the company which owns the rights to TSO in in the United States and Japan. They recently successfully completed their phase I trial and are embarking now on phase II, on their way to getting FDA approval for my beloved little whip worms. Right now they're concentrating efforts on Crohn's disease, with MS in 2nd place, but other autoimmune diseases are also being considered. They are working with Dr. Eric Hollander of Montefiore Medical Center on a study of TSO's effects on adults with autism. My hope is, this is just the first of many.I walked out of the dinner feeling very happy. Why? Because I genuinely believe that TSO couldn't be in more capable hands. What do I know but...I honestly feel that if anyone can get it FDA approved, and reimbursed by insurance, these people can. I called my parents on the way home and told them to buy more stock!TSO, helminthic therapy, is bigger than any one company and way bigger than any one person. But FDA approval is crucial in eventually getting the cost down to something affordable. Right now it is too expensive to help most people. I pray with all my heart that someday, all of us who need it for ourselves or our children will be able to do so.